CLDXNasdaq United States
Market cap
$3.274 B
$41.71 +0.36%
Close of 7 Aug 2026
Revenue
$1.54M
#3464 by revenue
Earnings
-$258.8M
Loss-making
Shares outstanding
78,529,532
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Celldex Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.